ResMed Inc. (ASX: RMD) shares have hit a 52-week low, but the valuation, earnings growth, and sleep health opportunity look ...

Miners helped cushion the ASX 200, but weakness across banks, tech and healthcare kept the index under pressure. With NAB ...

Discover Singapore-led innovations from global companies, including myopia-slowing lenses and Dyson vacuums, that are ...

ResMed’s first quarter saw the company deliver revenue and earnings above Wall Street expectations, yet the market responded ...

J.P. Morgan analyst Chris Cooper maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh yesterday and set a price target of A$37.10. The company’s shares ...

Julia Weng (Paradice) and Hamish FitzSimons (AllianceBernstein) diagnose ASX healthcare's brutal year and name the stocks set ...

CNBC’s Jim Cramer said today’s market may resemble 1999 in some ways, but investors are punishing stocks even more aggressively.

Following CSL’s second-largest one-day fall on record following an earnings downgrade, fresh questions have emerged over ...

Oil prices are rising as the war with Iran threatens to drag on for longer, but the US stock market is nevertheless inching ...

Treasurer Jim Chalmers is expected to raise the current $150 million cap on R&D expenses, even as the start-up sector fumes ...

Mining stocks have soared, but the banking and technology sectors dragged the ASX 200 lower, with the benchmark recording its ...

Local shares are poised to open up; energy paces modest gains in US equities; Fortescue court decision awaited; bitcoin briefly tops $US82,000. Follow live.